Literature DB >> 9466326

The positive charge of the imidazole side chain of histidine7 is crucial for GLP-1 action.

A Hareter1, E Hoffmann, H P Bode, B Göke, R Göke.   

Abstract

Glucagon-like peptide-1(7-36)amide/(7-37) (GLP-1) is an incretin hormone which plays an important role in postprandial glucose homeostasis. Since GLP-1 potentiates glucose-induced insulin secretion, stimulates insulin biosynthesis and inhibits glucagon release, it is a potential tool for the treatment of diabetes mellitus. For this, an exact understanding of the structural/functional moieties of the peptide is mandatory. The present study investigates the importance of structural features of histidine7 at the N-terminus for GLP-1 action. Based upon binding and activity data obtained from ten different GLP-1 analogues we show that not the positive charge of the free alpha-amino group but the positive charge of the imidazole side chain of histidine is crucial for GLP-1 action. The presence of a ring structure and a basic function as well as the correct positioning of both seems to be decisive.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466326     DOI: 10.1507/endocrj.44.701

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1.

Authors:  He Meng; Subrahmanian Tarakkad Krishnaji; Martin Beinborn; Krishna Kumar
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

4.  A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction.

Authors:  James T Patterson; Pengyun Li; Jonathan W Day; Vasily M Gelfanov; Richard D Dimarchi
Journal:  Mol Metab       Date:  2013-01-16       Impact factor: 7.422

5.  Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes.

Authors:  Fabio Selis; Rodolfo Schrepfer; Riccardo Sanna; Silvia Scaramuzza; Giancarlo Tonon; Simona Dedoni; Pierluigi Onali; Gaetano Orsini; Stefano Genovese
Journal:  Results Pharma Sci       Date:  2012-09-18

6.  Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.

Authors:  Bikash Manandhar; Jung-Mo Ahn
Journal:  J Med Chem       Date:  2014-11-13       Impact factor: 7.446

7.  A Non-Perturbative Molecular Grafting Strategy for Stable and Potent Therapeutic Peptide Ligands.

Authors:  Kathleen M Sicinski; Vittorio Montanari; Venkata S Raman; Jamie R Doyle; Benjamin N Harwood; Yi Chi Song; Micaella P Fagan; Maribel Rios; David R Haines; Alan S Kopin; Martin Beinborn; Krishna Kumar
Journal:  ACS Cent Sci       Date:  2021-02-15       Impact factor: 14.553

8.  Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.

Authors:  Ben Jones; Emma Rose McGlone; Zijian Fang; Phil Pickford; Ivan R Corrêa; Atsuro Oishi; Ralf Jockers; Asuka Inoue; Sunil Kumar; Frederik Görlitz; Chris Dunsby; Paul M W French; Guy A Rutter; Tricia Tan; Alejandra Tomas; Stephen R Bloom
Journal:  J Biol Chem       Date:  2020-12-04       Impact factor: 5.157

9.  Glucagon-like peptide-1 analogues: An overview.

Authors:  Vishal Gupta
Journal:  Indian J Endocrinol Metab       Date:  2013-05

10.  Compactness of Protein Folds Alters Disulfide-Bond Reducibility by Three Orders of Magnitude: A Comprehensive Kinetic Case Study on the Reduction of Differently Sized Tryptophan Cage Model Proteins.

Authors:  Dániel Horváth; Nóra Taricska; Ernő Keszei; Pál Stráner; Viktor Farkas; Gábor K Tóth; András Perczel
Journal:  Chembiochem       Date:  2019-11-18       Impact factor: 3.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.